Eppen_CellXpert_Feb25
  Editorial
 A GOOD BUDGET FOR HEALTHCARE SECTOR   
 Wednesday, February 5, 2025 
 In the Union Budget 2025, Union Finance Minister Nirmala Sitharaman has announced a slew of good initiatives for the healthcare sector in the country. 
  Past Editorial...  
Waters_Ebook_Dec24
TODAY'S NEWS
12:00  [IST]Roche announces detailed analysis of phase III REGENCY trial of Gazyva/Gazyvaro in people with active lupus nephritis published in the New England Journal of Medicine
11:00  [IST]Saudi Arabia pioneers advanced cancer care in the GCC with cutting-edge oncology centres
10:00  [IST]Barentz expands distribution partnership with Corum in Malaysia & Singapore
09:00  [IST]Lipella Pharma receives US FDA nod for expanded access programme for LP-310, an oral rinse formulation to treat oral lichen planus
more news >>
TOP NEWS
08:00  [IST]Budget allocation to DHR witness 40% increase in FY26
08:00  [IST]India needs to develop strategies to mitigate the impact of USAID funding freeze
08:00  [IST]TN IPA starts training programme for B Pharm & M Pharm students to be appointed in manufacturing companies
08:00  [IST]OET paves the way for global healthcare careers: Amit Upadhyay
08:00  [IST]Advanced therapies, medicines bring new hope for pulmonary hypertension patients: Dr Manisha Mendiratta
08:00  [IST]FPME hails rollback of track and trace system by Union commerce ministry
more news >>
YESTERDAY'S NEWS
18:00  [IST]Revalesio updates new analyses from phase 2 RESCUE clinical study of RNS60 in patients with acute ischemic stroke
17:00  [IST]Essential Pharma & Clinigen expand collaboration to improve patient access in JAPAC
16:00  [IST]Actimed Therapeutics’ anti-catabolic and pro-anabolic transforming agent, S-pindolol benzoate receives US & European patents
15:00  [IST]CIRM awards US$ 4 mn grant to Entos Pharma to advance development of ENTLEP001, a durable and redosable genetic medicine to treat CGL
14:00  [IST]Merck initiates phase 3 waveLINE-010 trial Initiation of zilovertamab vedotin, an investigational ADC to treat patients with previously untreated DLBCL
11:45  [IST]Indian pharma expected to grow at 9-10% in FY26, says Ind-Ra Ratings
more news >>
INTERVIEW  
Molbio Diagnostics redefines molecular diagnostics with Truenat
Shiva Sriram, President of Molbio Diagnostics
Past Interviews...
 
  What's New?  
 
Opinion Poll
 
 
Will the introduction of Revised Schedule M by Union Health Ministry solve the issue of quality of Indian drugs?
 
 
 
   
 
  Corporate
Pharma Stocks
Executive Diary
Pharma People
Product Launches
  Special Features
Features
  Chronicle Pharmabiz Specials
Forthcoming
  Past
 
  Forthcoming Events
International
  Domestic
 
TENDERS & PROJECTS
Tenders & Enquiries
Pharma Projects
CORPORATE
Company Profile
Corporate Results
Corporate X-ray
Pharmabiz Studies of Top Companies
US FDA UPDATE
US FDA: ANDA
US FDA: Warnings
US FDA: Approved NMEs
US FDA: New Approvals
EXPORT & IMPORT
Drug Export Procedures
Drug Units With WHO GMP Certification
Pharma Export Data
Import Reg. Update
PHARMA LAWS & DOCUMENTS
Notifications
Pharma Regulations
Patent Laws and Amendments
Patent Scan
Documents
New Drug Approvals
Notified Prices
LIST OF LABS & GOVT. BODIES
Govt Recognised In-House R&D Units
AICTE Boards & Committees
List of Indian CROs
List of CROs (International)
Govt & approved labs of India
List of State Drugs Controllers
 
 
Avians_2025
Asia_Lab_Expo2025
chemexpoindia
ana-Lab-India_25
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram